You searched for: astrazeneca

Stable outlook for AstraZeneca

AstraZeneca's gefurulimab shows positive phase III results

AstraZeneca receives EU approval for Koselugo

Nanoform enters strategic partnership with Revio Therapeutics

Nanoform and Revio Therapeutics have entered into a collaboration to develop GLIORA, a nanoformulated hydrogel for local and long-acting...

Privately held AAX Biotech gains global validation through Daiichi Sankyo agreement

Solna-based biotech company AAX Biotech has initiated a collaboration with Japanese pharmaceutical giant Daiichi Sankyo on its Opti-mAb platform for stabilizing...

List: The top women re-wiring Nordic life Science

From the labs in Copenhagen to the boardrooms in Stockholm and Oslo, on to the growth hubs in Turku and Helsinki – a...

Cinclus Pharma strengthens its position ahead of market approval – receives positive feedback from FDA

Cinclus Pharma continues to make progress in the development of the drug candidate linaprazan glurate. After initiating its...

AstraZeneca receives EU approval for Tezspire

The pharmaceutical sector is riding a USD 61,6 billion R&D wave

The pharmaceutical industry is accelerating with 104 R&D deals in Q3 2025 – about the same number as in Q2, but at a...

News wave from AstraZeneca in connection with ESMO 2025

AstraZeneca delivered a number of positive news during the ESMO Congress 2025 in Berlin. Among other things, phase III results for Enhertu were presented in...

AstraZeneca's Imfinzi reduces risk of death by 22 percent

Biotech shows increasing signs of life – is there more upside?

Biotech has had difficulty keeping up with the stock market upswing for several years, but recently we have started...